<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:wfw="http://wellformedweb.org/CommentAPI/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:atom="http://www.w3.org/2005/Atom"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
>
<channel>
	<title>ThaiPR.NET</title>
	<atom:link href="https://www.thaipr.net/location/toronto-on/feed" rel="self" type="application/rss+xml" />
	<link>https://www.thaipr.net/location/toronto-on</link>
	<description>Press Release Distribution Center of Thailand</description>
	<lastBuildDate>Thu, 30 Apr 2026 18:05:11 +0700</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.1.1</generator>
	<item>
		<title><![CDATA[Canadian pilot study suggests prescription icosapent ethyl (VASCEPA®) might improve symptoms of COVID-19 and reduce inflammation]]></title>
		<link>https://www.thaipr.net/en/general_en/3010067</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Tue, 15 Dec 2020 09:42:29 +0700</pubDate>
				<category>general_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/en/general_en/3010067</guid>

					<description><![CDATA[<p>The results of a Canadian study released this weekend provides encouraging data suggesting that the prescription strength omega-3 called icosapent ethyl (VASCEPA) may reduce inflammation and improve symptoms in patients with a diagnosis of COVID-19. &#8220;This study provides the first evidence of an early anti-inflammatory effect of icosapent ethyl in symptomatic COVID-19 positive outpatients – [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/general_en/3010067">Canadian pilot study suggests prescription icosapent ethyl (VASCEPA®) might improve symptoms of COVID-19 and reduce inflammation</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
	</channel>
</rss>
